Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

StocksToTrade
stockstotrade.com > news > twistbiosciencecorporation-twst-news-2026_08_21

Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook

3+ week, 2+ day ago   (356+ words) StocksToTrade Twist Bioscience Stock Surges As Anthropic AI Deal And Upbeat Guidance Reset Outlook Twist Bioscience Corporation stocks have been trading up by 6.79 percent amid strong investor optimism following its latest developments. JOIN 50,000+ ACTIVE TRADERS What Traders Need To Know…...

StocksToTrade
stockstotrade.com > news > biontech-se-bntx-news-2026_08_19-4

BioNTech SE Stock Jumps As Traders Bet On Post-COVID Pivot

3+ week, 4+ day ago   (477+ words) BioNTech SE stocks have been trading up by 23.44 percent amid optimism over its latest oncology pipeline progress. BNTX has traded like a coiled spring over the last few sessions. The daily chart shows the stock grinding around the low-$90s for…...

StocksToTrade
stockstotrade.com > news > biontech-se-bntx-news-2026_08_19-3

BioNTech SE Stock Pops As Traders Refocus On Oncology Pivot

3+ week, 4+ day ago   (311+ words) BioNTech SE stocks have been trading up by 20.92 percent following positive sentiment around its latest mRNA oncology advancements. BNTX has been trading like a classic catalyst name. On 2026/08/19, BioNTech SE closed at $112.17 after touching an intraday high of $116, a strong…...

Google News
stockstotrade.com > news > biontech-se-bntx-news-2026_08_19-2

BioNTech SE Stock Jumps As Traders Refocus On Oncology Pivot

3+ week, 4+ day ago   (282+ words) BioNTech SE stocks have been trading up by 19.94 percent following upbeat sentiment on its next-generation mRNA pipeline. Intraday, BNTX showed classic momentum behavior. The stock spiked hard off pre‑market levels near $100, ripped through $110, and briefly tagged $116 before cooling into…...

Google News
stockstotrade.com > news > biontech-se-bntx-news-2026_08_19

BioNTech SE Stock Draws Traders As Covid Fades, Oncology Story Builds

3+ week, 4+ day ago   (480+ words) BioNTech SE stocks have been trading up by 16.44 percent amid upbeat sentiment around its advancing mRNA pipeline. Key Takeaways For BNTX Traders Q2 2026 showed sharply lower COVID-19 revenues and wider losses, but BioNTech highlighted a hefty €16.6B cash pile, active buybacks, and…...